Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-25-001752
Filing Date
2025-11-14
Accepted
2025-11-14 16:11:46
Documents
85
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q igc10q093025.htm   iXBRL 10-Q 722835
2 EXHIBIT 31.1 igcex31-1.htm EX-31.1 14266
3 EXHIBIT 31.2 igcex31-2.htm EX-31.2 14380
4 EXHIBIT 32.1 igcex32-1.htm EX-32.1 7669
5 GRAPHIC image_001.jpg GRAPHIC 4511
6 GRAPHIC image_002.jpg GRAPHIC 56222
  Complete submission text file 0001185185-25-001752.txt   5233105

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE igc-20250930.xsd EX-101.SCH 52574
8 XBRL CALCULATION FILE igc-20250930_cal.xml EX-101.CAL 36720
9 XBRL DEFINITION FILE igc-20250930_def.xml EX-101.DEF 223328
10 XBRL LABEL FILE igc-20250930_lab.xml EX-101.LAB 413187
11 XBRL PRESENTATION FILE igc-20250930_pre.xml EX-101.PRE 246368
88 EXTRACTED XBRL INSTANCE DOCUMENT igc10q093025_htm.xml XML 597986
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-529-4996
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-32830 | Film No.: 251486238
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)